Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Varian Medical Systems Inc (VAR) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$N/A after a previous close of US$N/A. During the day the price has varied from a low of USDN/A to a high of USDN/A. Varian Medical Systems is listed on the NYSE. All prices are listed in US Dollars.
|52-week range||US$174.65 - US$177.38|
|50-day moving average||US$176.5655|
|200-day moving average||US$174.8939|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$3.032|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Varian Medical Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Varian Medical Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Varian Medical Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 58x. In other words, Varian Medical Systems shares trade at around 58x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Varian Medical Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.8298. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Varian Medical Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Varian Medical Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$524.5 million (£0.0 million).
The EBITDA is a measure of a Varian Medical Systems's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$3.1 billion|
|Operating margin TTM||13.63%|
|Gross profit TTM||US$1.4 billion|
|Return on assets TTM||5.92%|
|Return on equity TTM||13.51%|
|Market capitalisation||US$16.3 billion|
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Varian Medical Systems.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 26.98
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Varian Medical Systems's overall score of 26.98 (as at 12/31/2018) is nothing to write home about – landing it in it in the 49th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Varian Medical Systems is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 6.23/100
Varian Medical Systems's environmental score of 6.23 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Varian Medical Systems is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 15.82/100
Varian Medical Systems's social score of 15.82 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that Varian Medical Systems is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 12.93/100
Varian Medical Systems's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that Varian Medical Systems is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Varian Medical Systems scored a 1 out of 5 for controversy – the highest score possible, reflecting that Varian Medical Systems has managed to keep its nose clean.
|Total ESG score||26.98|
|Total ESG percentile||48.96|
|Environmental score percentile||4|
|Social score percentile||4|
|Governance score percentile||4|
|Level of controversy||1|
We're not expecting Varian Medical Systems to pay a dividend over the next 12 months.
Varian Medical Systems's shares were split on a 10000:8769 basis on 29 January 2017. So if you had owned 8769 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Varian Medical Systems shares – just the quantity. However, indirectly, the new 12.3% lower share price could have impacted the market appetite for Varian Medical Systems shares which in turn could have impacted Varian Medical Systems's share price.
Over the last 12 months, Varian Medical Systems's shares have ranged in value from as little as US$174.65 up to US$177.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Varian Medical Systems's is 1.0695. This would suggest that Varian Medical Systems's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets; and collaboration with Google Cloud. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
The Sixers and Thunder clash in the biggest Sydney Derby in the history of the Big Bash League.
Who will be declared House Cup Champion?
Will Mickey Donovan finally die in this wrap-up movie?
Don't fall for the scam artists when you're trying to protect your health - here's what to check.
Here's where you can book COVID-19 at-home tests approved for travel and how they work.
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Drac and the Pack are back, like you’ve never seen them before.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.